142 related articles for article (PubMed ID: 7688703)
1. MMQ cells: a model for evaluating the role of G proteins in the modulation of prolactin release.
Forget H; Painson JC; Drews RT; Lagacé G; Collu R
Mol Cell Endocrinol; 1993 Jun; 93(2):125-33. PubMed ID: 7688703
[TBL] [Abstract][Full Text] [Related]
2. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
Bouvier C; Forget H; Lagacé G; Drews R; Sinnett D; Labuda D; Collu R
Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine.
Judd AM; Login IS; Kovacs K; Ross PC; Spangelo BL; Jarvis WD; MacLeod RM
Endocrinology; 1988 Nov; 123(5):2341-50. PubMed ID: 2844508
[TBL] [Abstract][Full Text] [Related]
4. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
5. Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.
Yajima Y; Uchino K; Ito H; Kawashima S
Endocrinology; 1997 May; 138(5):1949-58. PubMed ID: 9112392
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
7. Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3',5'-monophosphate production in lactotroph cells.
Audinot V; Rasolonjanahary R; Bertrand P; Priam M; Kordon C; Enjalbert A
Endocrinology; 1991 Oct; 129(4):2231-9. PubMed ID: 1655395
[TBL] [Abstract][Full Text] [Related]
8. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic regulation of basal versus thyrotropin-releasing hormone-induced prolactin secretion in rat anterior pituitary cells. differential roles of nitric oxide and intracellular calcium mobilization.
Pu HF; Tan SK; Chen HL; Jea JC; Liu TC
Neuroendocrinology; 1999 Nov; 70(5):324-31. PubMed ID: 10567858
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells.
Yajima Y; Akita Y; Saito T
J Biol Chem; 1986 Feb; 261(6):2684-9. PubMed ID: 2869031
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
12. Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.
Delahunty TM; Cronin MJ; Linden J
Biochem J; 1988 Oct; 255(1):69-77. PubMed ID: 2848512
[TBL] [Abstract][Full Text] [Related]
13. Alpha-adrenergic inhibition of thyrotropin-releasing hormone-induced prolactin secretion in GH4C1 cells is associated with a depressed rise in intracellular Ca2+.
Inukai T; Wang X; Greer MA
Mol Cell Endocrinol; 1992 Sep; 87(1-3):29-34. PubMed ID: 1280233
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated stimuli on prolactin release in vitro from normal and adenomatous rat lactotrophs.
Lafond J; Collu R
Mol Cell Endocrinol; 1986 Sep; 47(1-2):175-81. PubMed ID: 3091427
[TBL] [Abstract][Full Text] [Related]
15. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
Kineman RD; Gettys TW; Frawley LS
J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
[TBL] [Abstract][Full Text] [Related]
16. The intrinsic activity of (-)-3-PPP vis-à-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release.
Nilsson CL; Hellstrand M; Ekman A; Eriksson E
Neuropharmacology; 1998; 37(2):233-42. PubMed ID: 9680248
[TBL] [Abstract][Full Text] [Related]
17. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
[TBL] [Abstract][Full Text] [Related]
18. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
19. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
